New pill offers hope for Tough-to-Treat cancers
Disease control
Recruiting now
This study is testing an experimental daily pill called ABP1011T for people with advanced solid tumors, like certain lung, esophageal, and cervical cancers, who have already tried and stopped responding to standard treatments. The main goal is to see if the pill can shrink tumors…
Phase: PHASE2 • Sponsor: Shanghai AB PharmaTech Ltd. • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC